According to a study published in the Lancet medical journal on Thursday, an experimental vaccine against the Ebola virus was found to be 100 percent effective. The results offer hope of better protection against the disease that ravaged West Africa in 2014, killing more than 11, 000 people. From a report on BBC: A highly effective vaccine that guards against the deadly Ebola virus could be available by 2018, says the World Health Organization. Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show it offers 100% protection. The vaccine is now being fast-tracked for regulatory approval. Manufacturer Merck has made 300, 000 doses of the rVSV-ZEBOV vaccine available for use should Ebola strike. GAVI, the global vaccine alliance, provided $5m for the stockpile. Results, published in The Lancet medical journal, show of nearly 6, 000 people receiving the vaccine, all were free of the virus 10 days later. In a group of the same size not vaccinated, 23 later developed Ebola. Only one person who was vaccinated had a serious side effect that the researchers think was caused by the jab. Read more of this story at Slashdot.
See the article here:
Ebola Vaccine Gives 100 Percent Protection, Could Be Readily Available By 2018
